These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1819712)

  • 1. Cardiovascular effects of platelet-activating factor.
    Goldstein RE; Feuerstein GZ; Bradley LM; Stambouly JJ; Laurindo FR; Davenport NJ
    Lipids; 1991 Dec; 26(12):1250-6. PubMed ID: 1819712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hypotension produced by platelet-activating factor.
    Laurindo FR; Goldstein RE; Davenport NJ; Ezra D; Feuerstein GZ
    J Appl Physiol (1985); 1989 Jun; 66(6):2681-90. PubMed ID: 2745330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses.
    Bradley LM; Stambouly JJ; Czaja JF; Goldstein RE
    Pediatr Res; 1989 Sep; 26(3):175-9. PubMed ID: 2587116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
    Davenport NJ; Goldstein RE; Feuerstein GZ
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):641-6. PubMed ID: 1711633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory effects of PAF-acether in newborn piglets.
    Bradley LM; Goldstein RE; Feuerstein G; Czaja JF
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H205-12. PubMed ID: 2912183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs.
    Olson NC; Kruse-Elliott KT; Whorton AR; Dodam JR
    Am J Physiol; 1993 Mar; 264(3 Pt 1):L213-21. PubMed ID: 8460710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig.
    Ezra D; Laurindo FR; Czaja JF; Snyder F; Goldstein RE; Feuerstein G
    Prostaglandins; 1987 Jul; 34(1):41-57. PubMed ID: 3685397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
    Felsen D; Loo MH; Marion DN; Vaughan ED
    J Urol; 1990 Jul; 144(1):141-5. PubMed ID: 2141654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained effects of platelet-activating factor infusion in piglets.
    Stambouly JJ; Bradley LM; Czaja JF; Goldstein RE
    Pediatr Res; 1991 Sep; 30(3):261-5. PubMed ID: 1945566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vascular response to platelet-activating factor in conscious sheep.
    Toyofuku T; Kobayashi T; Koyama S; Kusama S
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H434-40. PubMed ID: 3414811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative mechanism of hypotensive action of platelet-activating factor in dogs.
    Yamanaka S; Miura K; Yukimura T; Okumura M; Yamamoto K
    Circ Res; 1992 May; 70(5):893-901. PubMed ID: 1568300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of thromboxane on pulmonary arterial response to platelet activating factor in rabbit].
    Enzan K; Komatsu H; Shoji K; Suzuki M
    Masui; 1995 May; 44(5):633-42. PubMed ID: 7609288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.
    Takehana Y; Hamano S; Kikuchi S; Komatsu H; Okegawa T; Ikeda S
    Jpn J Pharmacol; 1990 Apr; 52(4):621-30. PubMed ID: 2160552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of platelet-activating factor and thromboxane in group B Streptococcus-induced pulmonary hypertension in piglets.
    Pinheiro JM; Pitt BR; Gillis CN
    Pediatr Res; 1989 Nov; 26(5):420-4. PubMed ID: 2682499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
    Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
    J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
    Reyes AA; Klahr S
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2.
    Badr KF; DeBoer DK; Takahashi K; Harris RC; Fogo A; Jacobson HR
    Am J Physiol; 1989 Jan; 256(1 Pt 2):F35-43. PubMed ID: 2912165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.